Results 171 to 180 of about 69,829 (275)

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

, 2000
Alain Landau, Dominique Batisse, Christophe Piketty, Raymond Jian, Michel D. Kazatchkine   +4 more
openalex   +1 more source

Nipah virus: a summary for clinicians. [PDF]

Int J Emerg Med
Levine CB, Sauer LM, McLellan SLF, Evans JD, State of the Science Working Group of the National Ebola Training and Education Center’s (NETEC’s) Special Pathogens Research Network (SPRN).   +4 more
europepmc   +1 more source

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). [PDF]

Viruses
Di Marco L, Cannova S, Ferrigno E, Landro G, Nonni R, Mantia C, Cartabellotta F, Calvaruso V, Di Marco V.   +8 more
europepmc   +1 more source

Neoadjuvant PD-1 blockade induces the autophagy of immune cells: a new target for synergistic therapy of recurrent glioblastoma. [PDF]

Biochem Biophys Rep
Xuan Z, Wang K, Zhu Q, Sun T, Jiang J, Wu Z, Zheng S, Zhao H.   +7 more
europepmc   +1 more source

TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION WITH INTERFERON ALFA 2B AND RIBAVIRIN.

, 2000
Fausto Zamboni, A Franchello, Bruna Lavezzo, Paolo Strignano, M. Schellino, Mario Rizzetto, Mauro Salizzoni   +6 more
openalex   +1 more source

Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.

New England Journal of Medicine, 2013
E. Gane, C. Stedman, R. Hyland, Xiao Ding, E. Svarovskaia, W. Symonds, R. Hindes, M. Berrey   +7 more
semanticscholar   +1 more source

Author Correction: Structural basis for the activation of plant bunyavirus replication machinery and its dual-targeted inhibition by ribavirin. [PDF]

Nat Plants
Li J, Cao L, Zhao Y, Shen J, Wang L, Feng M, Zhu M, Ye Y, Kormelink R, Tao X, Wang X.   +10 more
europepmc   +1 more source

Low dose ribavirin for six months plus interferon 5 MU TIW for 1 year is effective in the treatment of hepatitis C patients who were initially either relapsers or non-responders to interferon monotherapy

, 2000
David Bernstein, Lennox J. Jeffers, Gerard Lake-Bakaar   +2 more
openalex   +1 more source

Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus

Antimicrobial Agents and Chemotherapy, 2018
D. Babusis, M. Curry, B. Kirby, Yeojin Park, E. Murakami, Ting Wang, A. Mathias, N. Afdhal, J. Mchutchison, A. Ray   +9 more
semanticscholar   +1 more source

The Combination of GS-441524 (Remdesivir) and Ribavirin Results in a Potent Antiviral Effect Against Human Parainfluenza Virus 3 Infection in Human Airway Epithelial Cell Cultures and in a Mouse Infection Model. [PDF]

Viruses
Lin Y, Weynand B, Zhang X, Laporte M, Jochmans D, Neyts J.   +5 more
europepmc   +1 more source